| Line Item | 2025-05-03 | Y/Y |
|---|---|---|
| Revenue | $436.8M | +126.3% |
| Cost of Revenue | $153.9M | +109.2% |
| Gross Profit | $282.9M | +136.9% |
| R&D Expense | $146.0M | +52.8% |
| SG&A Expense | $98.9M | +64.3% |
| Operating Income | $37.1M | +200.2% |
| Pre-tax Income | $54.9M | +341.2% |
| Income Tax | $2.7M | -52.2% |
| Net Income | $52.2M |
| Line Item | 2025-05-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.3M | +253.0% |
| Short-term Investments | $195.0M | -43.2% |
| Accounts Receivable | $162.1M | +171.8% |
| Inventory | $90.0M | +247.5% |
| Current Assets | $713.5M | +34.6% |
| Total Assets | $809.3M | +34.4% |
| Current Liabilities | $107.7M | +141.4% |
| Line Item | 2025-05-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65.1M | +98.8% |
| Capital Expenditures | $36.1M | +130.4% |
| Investing Cash Flow | $112.0M | +144.9% |
| Financing Cash Flow | -$7.7M | -104.4% |
| Free Cash Flow | $29.0M | +69.9% |
| +283.9% |
| EPS (Basic) | $0.31 | +272.2% |
| EPS (Diluted) | $0.29 | +261.1% |
| Total Liabilities |
| $127.7M |
| +106.8% |
| Stockholders' Equity | $681.6M | +26.2% |